These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16639877)

  • 1. Combined n-benzoyl-d-phenylalanine and metformin treatment reverses changes in the fatty acid composition of streptozotocin diabetic rats.
    Kumar NA; Pari L
    J Basic Clin Physiol Pharmacol; 2006; 17(1):17-28. PubMed ID: 16639877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of N-benzoyl-D-phenylalanine on streptozotocin-induced changes in the lipid and lipoprotein profile in rats.
    Ashokkumar N; Pari L; Manimekalai A; Selvaraju K
    J Pharm Pharmacol; 2005 Mar; 57(3):359-66. PubMed ID: 15807992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of N-benzoyl-d-phenylalanine on lipid profile in liver of neonatal streptozotocin diabetic rats.
    Pari L; Ashokkumar N
    Fundam Clin Pharmacol; 2005 Oct; 19(5):563-8. PubMed ID: 16176335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of N-benzoyl-D-phenylalanine and metformin on insulin receptors in neonatal streptozotocin-induced diabetic rats: studies on insulin binding to erythrocytes.
    Ashokkumar N; Pari L; Rao ChA
    Arch Physiol Biochem; 2006 Jul; 112(3):174-81. PubMed ID: 17132543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of N-benzoyl-D-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats.
    Ashokkumar N; Pari L
    Clin Chim Acta; 2005 Jan; 351(1-2):105-13. PubMed ID: 15563878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of N-benzoyl-D-phenylalanine, a new potential oral antidiabetic agent, in neonatal streptozotocin-induced diabetes in rats.
    Pari L; Ashokkumar N
    Pharmacol Rep; 2005; 57(4):498-503. PubMed ID: 16129917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of Phaseolus vulgaris on changes in the fatty acid composition in experimental diabetes.
    Pari L; Venkateswaran S
    J Med Food; 2004; 7(2):204-9. PubMed ID: 15298769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein changes in non-insulin dependent diabetic rats: effect of N-benzoyl-D-phenylalanine and metformin.
    Pari L; Ashokkumar N
    Therapie; 2006; 61(2):125-31. PubMed ID: 16886705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of Umbelliferone on membranous fatty acid composition in streptozotocin-induced diabetic rats.
    Ramesh B; Viswanathan P; Pugalendi KV
    Eur J Pharmacol; 2007 Jul; 566(1-3):231-9. PubMed ID: 17477917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of 20-OH ecdysone on lipid profile and tissue fatty acid changes in streptozotocin induced diabetic rats.
    Naresh Kumar R; Sundaram R; Shanthi P; Sachdanandam P
    Eur J Pharmacol; 2013 Jan; 698(1-3):489-98. PubMed ID: 23110815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Helicteres isora administration for diabetes mellitus: the effect on changes in tissue fatty acid composition.
    Kumar G; Banu S; Murugesan AG
    Food Chem Toxicol; 2009 Aug; 47(8):1826-30. PubMed ID: 19410628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scutellaria baicalensis enhances the anti-diabetic activity of metformin in streptozotocin-induced diabetic Wistar rats.
    Waisundara VY; Hsu A; Huang D; Tan BK
    Am J Chin Med; 2008; 36(3):517-40. PubMed ID: 18543386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of Coccinia indica on changes in the fatty acid composition in streptozotocin induced diabetic rats.
    Pari L; Venkateswaran S
    Pharmazie; 2003 Jun; 58(6):409-12. PubMed ID: 12857005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorative potential of S-allylcysteine: effect on lipid profile and changes in tissue fatty acid composition in experimental diabetes.
    Saravanan G; Ponmurugan P
    Exp Toxicol Pathol; 2012 Sep; 64(6):639-44. PubMed ID: 21216577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Succinic acid monoethyl ester, a novel insulinotropic agent: effect on lipid composition and lipid peroxidation in streptozotocin-nicotin-amide induced type 2 diabetic rats.
    Saravanan R; Pari L
    Mol Cell Biochem; 2007 Feb; 296(1-2):165-76. PubMed ID: 17006620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rosiglitazone and nateglinide on serum glucose and lipid profile alone or in combination with the biguanide metformin in diabetic rats.
    El-Batran SA; Abdel-Salam OM; Nofal SM; Baiuomy AR
    Pharmacol Res; 2006 Jan; 53(1):69-74. PubMed ID: 16214362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of metformin on glutathione and magnesium in normal and streptozotocin-induced diabetic rats.
    Ewis SA; Abdel-Rahman MS
    J Appl Toxicol; 1995; 15(5):387-90. PubMed ID: 8666722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin improves lipid metabolism and attenuates lipid peroxidation in high fructose-fed rats.
    Anurag P; Anuradha CV
    Diabetes Obes Metab; 2002 Jan; 4(1):36-42. PubMed ID: 11874440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of preventative application of metformin on bile acid metabolism in high fat-fed/streptozotocin-diabetic rats.
    Ding L; Qu Z; Chi J; Shi R; Wang L; Hou L; Wang Y; Pang S
    Int J Clin Exp Pathol; 2015; 8(5):5450-6. PubMed ID: 26191249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic and antihyperlipidemic activities of a novel polyherbal formulation in high fat diet/streptozotocin induced diabetic rat model.
    Subhasree N; Kamella A; Kaliappan I; Agrawal A; Dubey GP
    Indian J Pharmacol; 2015; 47(5):509-13. PubMed ID: 26600639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.